| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $4.74B | $4.88B | $3.22B |
| YoY Revenue Growth % | -3.1% | +51.5% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $835.0M | $30.9M | $375.8M |
| Operating Margin % | 17.6% | 0.6% | 11.7% |
| Net Income (GAAP) | $546.3M | $6.4M | $175.7M |
| EBITDA (Normalized) | $1.01B | $206.8M | $491.9M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $1.29B | $586.1M | $266.2M |
| Capital Expenditures (CapEx) | $213.1M | $219.8M | $145.1M |
| Free Cash Flow (FCF) | $1.07B | $366.3M | $121.0M |
| FCF Margin % | 22.7% | 7.5% | 3.8% |
| Return on Invested Capital (ROIC %) | 9.9% | 0.4% | 2.6% |
| Cash & Short-Term Equivalents | $831.1M | $619.8M | — |
| Total Debt (Short + Long Term) | $3.72B | $2.74B | $4.35B |
| Total Stockholders' Equity | $3.74B | $4.09B | $8.93B |